Early HIV screening and cART initiation vital for preventing brain atrophy

New research, recently published in Clinical Infectious Diseases, has emphasized the importance of early screening and initiation of antiviral therapy in avoiding brain neurological consequences.

By the end of 2016, 36.7 million individuals were living with HIV, of whom only 53% had access to combination antiretroviral therapy (cART).

It is well known among the scientific community that infection with HIV causes reduced volume and cortical thickness in various regions of the brain; however, it remains unknown at what time point these side effects occur post-infection.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment